Summary Of [14C]-Resminostat - Innovative Product

Chemical Name

[14C]-Resminostat

CAS No.

--

Molecular Formula

--

Innovator

Developer

Indication

Cutaneous T Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome

Therapeutic Area

Hematology; Oncology

Market Status

Phase 4

Approval Year

Patent Expiry